Gennaro Daniele
- Oncology top 5%
- HER2/EGFR in Cancer Research 16
- Colorectal Cancer Treatments and Studies 16
- Lung Cancer Research Studies 15
- Cancer Treatment and Pharmacology 14
- Hepatology top 5%
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 16
-
- Lung Cancer Treatments and Mutations 31
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 11
-
- Health Systems, Economic Evaluations, Quality of Life 9
- Co-authors
- Francesco PerroneFortunato CiardielloMaria Carmela PiccirilloGiampaolo TortoraRoberto BiancoMassimo Di MaïoAlessandro MorabitoGaetano Rocco
- Journals
- Journal of Clinical Oncology (18 papers)SHILAP Revista de lepidopterología (5 papers)PLoS ONE (2 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Gennaro Daniele
90 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Oncology 970
- Hepatology 159
- Reproductive Medicine 158
- Pulmonary and Respiratory Medicine 577
- Cancer Research 262
Countries citing papers authored by Gennaro Daniele
This map shows the geographic impact of Gennaro Daniele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gennaro Daniele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gennaro Daniele more than expected).
Fields of papers citing papers by Gennaro Daniele
This network shows the impact of papers produced by Gennaro Daniele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gennaro Daniele. The network helps show where Gennaro Daniele may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gennaro Daniele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 18 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 29 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 29 | |
| 14 | 2021 | 10 | |
| 15 | 2021 | 30 | |
| 16 | 2021 | 2 | |
| 17 | 2020 | 2 | |
| 18 | 2016 | 108 | |
| 19 | Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trialsbreakdown → | 2015 | 330 |
| 20 | 2008 | 117 |
About Gennaro Daniele
Gennaro Daniele is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 100 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (31 papers), HER2/EGFR in Cancer Research (16 papers), Colorectal Cancer Treatments and Studies (16 papers), Ovarian cancer diagnosis and treatment (16 papers), Lung Cancer Research Studies (15 papers), Cancer Treatment and Pharmacology (14 papers), Cancer Genomics and Diagnostics (11 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). The work is most often cited by research in Oncology (970 citations), Hepatology (159 citations) and Reproductive Medicine (158 citations). Gennaro Daniele has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Francesco Perrone, Fortunato Ciardiello, Maria Carmela Piccirillo, Giampaolo Tortora, Roberto Bianco, Massimo Di Maïo, Alessandro Morabito, Gaetano Rocco, Giovanni Scambia and Jane Bryce. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.